Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.
NCT ID: NCT03943186
Last Updated: 2019-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
102 participants
OBSERVATIONAL
2018-12-13
2019-05-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of a Sore Throat Lozenge DORITHRICIN in Patients With Acute Pharyngitis
NCT03323528
Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract
NCT04633187
Etoposide in the First-line Treatment of Adult EBV-HLH
NCT03742115
Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection
NCT04308278
Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19
NCT05817045
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Efficacy will be studied by documentation of the following symptoms:
* pain on swallowing
* hoarseness
* urge to cough
* dry mouth and throat
* redness of oropharynx and larynx
* sore throat
* impairment of free breathing
* general feeling of illness
In parallel, participating patients will document their symptoms over the entire study duration in patient diaries.
The observation takes place over a period of seven days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ectoin Lozenges Honey Lemon
application of 1 Lozenge every three hours or as often as required, not more than 10 lozenges per day
Ectoin Lozenges Honey Lemon
application of Ectoin Lozenges (EHT02) in accordance with the instructions for use
Hyaluronic acid/Icelandic moss Lozenges
application as often as required, not more than 6 lozenges per day
Hyaluronic Acid/Icelandic moss Lozenges
application of the lozenges in accordance with the instructions for use
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ectoin Lozenges Honey Lemon
application of Ectoin Lozenges (EHT02) in accordance with the instructions for use
Hyaluronic Acid/Icelandic moss Lozenges
application of the lozenges in accordance with the instructions for use
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
* Surgical Procedures in the mouth and throat region prior to the study
* Bacterial Pharyngitis
* symptoms in the throat since more than 5 days
* Contraindications according to the instructions for use
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bitop AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Bilstein, Dr
Role: STUDY_DIRECTOR
CSO
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
bitop AG
Dortmund, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
btph-014-2018-EHT02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.